Physician
Neurosurgery
Dr. Ichiro Nakano, MD
Ichiro Nakano is an expert in the field of Neurosurgery. Ichiro Nakano, MD is a published doctor and has 24 publications published. The lastest was: 'Serine/Threonine Kinase MLK4 Determines Mesenchymal Identity in Glioma Stem Cells in an NF-B-dependent Manner.'
Publications
- EZH2 protects glioma stem cells from radiation-induced cell death in a MELK/FOXM1-dependent manner.
- Ras-mediated modulation of pyruvate dehydrogenase activity regulates mitochondrial reserve capacity and contributes to glioblastoma tumorigenesis.
- Extracellular vesicles in the biology of brain tumour stem cells - Implications for inter-cellular communication, therapy and biomarker development.
- Therapeutic potential of targeting glucose metabolism in glioma stem cells.
- Stem cell signature in glioblastoma: therapeutic development for a moving target.
- Neuronal ceroid lipofuscinosis genes, CLN2, CLN3 and CLN5 are spatially and temporally co-expressed in a developing mouse brain.
- Intercellular Cooperation and Competition in Brain Cancers: Lessons From Drosophila and Human Studies.
- Transcription factors as master regulator for cancer stemness: remove milk from fox?
- Detoxification of oxidative stress in glioma stem cells: Mechanism, clinical relevance, and therapeutic development.
- Ethics of iPSC-Based Clinical Research for Age-Related Macular Degeneration: Patient-Centered Risk-Benefit Analysis.
- Piperlongumine treatment inactivates peroxiredoxin 4, exacerbates endoplasmic reticulum stress, and preferentially kills high-grade glioma cells.
- Maternal Embryonic Leucine Zipper Kinase: Key Kinase for Stem Cell Phenotype in Glioma and Other Cancers.
- The AMPK Inhibitor Compound C Is a Potent AMPK-Independent Antiglioma Agent.
- Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3.
- MELK-dependent FOXM1 Phosphorylation is Essential for Proliferation of Glioma Stem Cells.
- Impairment of glioma stem cell survival and growth by a novel inhibitor for survivin-ran protein complex.
- Tumor-specific Activation of the c-JUN/MELK Pathway Regulates Glioma Stem Cell Growth in a p53-dependent Manner.
- A streamlined protocol for the use of the semi-sitting position in neurosurgery: a report on 48 consecutive procedures.
- ATLAS Run 1 searches for direct pair production of third-generation squarks at the Large Hadron Collider.
- Targeted Delivery of Tumor Suppressor microRNA-1 by Transferrin- Conjugated Lipopolyplex Nanoparticles to Patient-Derived Glioblastoma Stem Cells.
- Multi-Kinase Inhibitor C1 Triggers Mitotic Catastrophe of Glioma Stem Cells Mainly through MELK Kinase Inhibition.
- miR-21 in the Extracellular Vesicles (EVs) of Cerebrospinal Fluid (CSF): A Platform for Glioblastoma Biomarker Development.
- Serine/Threonine Kinase MLK4 Determines Mesenchymal Identity in Glioma Stem Cells in an NF-κB-dependent Manner.
Doctors Specialties
- Neurosurgery
Accepted Insurances
Helpful Reviews
Similar Doctors
|
Jacqueline S. King, NP |
|
|
Dr. John P. Johnson, MD |
|
|
Dr. Brian Pikul, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marshall Grode, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nader Pouratian, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Paul E. Kaloostian, MD |
|
Dr. Chirag G. Patil, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Joel S. Beckett, MD |
|
|
Dr. Eisha A. Christian, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel Hirt, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christina W. Huang, MD |
|
|
Dr. Taghi Tirgari, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard A. Robison, MD
This Doctor is OpenDoctor Recommended.
|